• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF1633
Device Problem Positioning Failure (1158)
Patient Problem Aneurysm (1708)
Event Date 01/23/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).According to the gore® dryseal flex introducer sheath instructions for use (ifu), adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vascular trauma (i.E., dissection, rupture, perforation, tear, etc.), or serious injury to the patient may result.
 
Event Description
On (b)(6) 2019, the patient underwent treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.It was reported during advancement of a 18fr gore® dryseal flex introducer sheath (dsf1833) into the right femoral artery, resistance was noted and the device was not able to be advanced due to calcification.Therefore, the sheath was replaced to a 16fr gore® dryseal flex introducer sheath (dsf1633).However, the 16fr sheath reportedly was unable to be advanced into the right femoral artery.Then the 16fr sheath was then reportedly attempted to be inserted into the left femoral artery, although the left femoral artery was also calcified.The attempted advancement of the 16fr gore® dryseal flex introducer sheath (dsf1633) to the left femoral artery was reportedly not successful.Percutaneous transluminal angioplasty of the right femoral artery was performed.The 16fr sheath was able to be inserted in to the right femoral artery.At this point, significant amount of bleeding (amount unknown) from both puncture sites and hypotension were observed.It was reported a blood transfusion was performed to treat the blood loss.
 
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® dryseal flex introducer sheath instructions for use (ifu), adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vascular trauma (i.E., dissection, rupture, perforation, tear, etc.), or serious injury to the patient may result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0)
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8350451
MDR Text Key136507582
Report Number3007284313-2019-00045
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00733132630028
UDI-Public00733132630028
Combination Product (y/n)N
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/21/2021
Device Catalogue NumberDSF1633
Device Lot Number18618309
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age92 YR
-
-